Ellen B. Kaplan

Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer

Susan Halabi, Eric J. Small, Philip W. Kantoff et al. · Journal of Clinical Oncology · 2003 · 679 citations

Medicine, Oncology, Urology +14

Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)

Eric J. Small, Susan Halabi, Nancy A. Dawson et al. · Journal of Clinical Oncology · 2004 · 502 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

William Kevin Kelly, Susan Halabi, Michael A. Carducci et al. · Journal of Clinical Oncology · 2012 · 483 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Susan Halabi, Chen‐Yen Lin, William K. Kelly et al. · Journal of Clinical Oncology · 2014 · 475 citations

Medicine, Biostatistics, Oncology +17

Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy

Susan Halabi, Chenyu Lin, Eric J. Small et al. · JNCI Journal of the National Cancer Institute · 2013 · 162 citations · Full text

Medicine, Biostatistics, Oncology +17